Health Care & Life Sciences » Biotechnology | Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.22
Market Cap
$360.38 M
Shares Outstanding
79.24 M
Public Float
26.55 M

Profile

Address
545, Promenade du Centropolis
Laval Québec H7T 0A3
Canada
Employees -
Website http://www.neptunecorp.com
Updated 07/08/2019
Neptune Technologies & Bioresources, Inc. engages in the development and commercialization specialty ingredients. It offers the MaxSimil a patented ingredient that may enhance the absorption of lipid-based nutraceuticals, and a variety of other marine and seed oils. It operates through the Nutraceutical, Cannabis, and Cardiovascular segments.

Financials

View All

James Hamilton
President, Chief Executive Officer & Director
Hélène F. Fortin
Director